This pharmaceutical composition, dosage form, and treatment method patent is part of a comprehensive IP portfolio covering naronapride, Renexxion's lead compound and a potential best-in-class, orally ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today provided an update on the status of its intellectual ...
On Monday, the USPTO announced that the agency has established a Standard-Essential Patent (SEP) Working Group to develop and ...
The cover is meant to improve aerodynamics and utility, but patent illustrations also suggest a potential, coincidental ...
On December 29, the U.S. Patent and Trademark Office (USPTO) announced the creation of a Standard-Essential Patent (SEP) Working Group. Deputy General Counsel for Intellectual Property Law, Solicitor ...
The United States Patent and Trademark Office has denied trademark applications for “Las Vegas Athletics” and “Vegas ...
GM has filed a patent application for an adaptive shock absorber with a mechanical design, potentially reducing complexity ...
The United States Patent and Trademark Office (USPTO) plays a critical role in supporting the American innovation ecosystem, and issuing high quality patents that will drive U.S. innovation. And for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback